About this trial
To explore whether a ReDS-guided strategy for AMI patients with cardiac insufficiency following coronary flow reperfusion is superior to routine care for improving outcomes.
Eligibility criteria
Qualifiers
Patients were required to be aged ≥ 18 years and to be hospitalized for a primary diagnosis of AMI,
AMI patients accompanied by cardiac insufficiency following coronary revascularization, which is characterized by the symptoms and signs of fluid overload, regardless of left ventricular ejection fraction (LVEF), and have an N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration of ≥ 400 pg/L or a BNP concentration of ≥ 100 pg/L.
Disqualifiers
Patient's physical characteristics that prevented the use of the ReDS system (height of <155 or >190 cm; body mass index of <22 or >39 kg/m2)
Patients with chronic obstructive pulmonary disease or other lung diseases that might confound ReDS values
Patients with a left ventricular assist device or undergoing cardiac transplantation;
Patients with congenital heart malformations or intrathoracic mass that would affect right lung anatomy;
Trial design
Treatments tested in this trial
- Remote dielectric sensing system